Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675878 · ClinicalTrials.gov registry record · Phase 3
Confirmation of Diet as a Treatment for Gulf War Illness
A Phase 3 study of Gulf War Illness and Gulf War Syndrome, sponsored by American University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
- 3
- Study locations
NCT05675878 is a Phase 3 study of Gulf War Illness and Gulf War Syndrome that is actively recruiting participants, run by American University. The registered enrollment target is 160 participants, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (36% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT05675878, a Phase 3 study of Gulf War Illness and Gulf War Syndrome, is actively recruiting participants, sponsored by American University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial aims to confirm previous findings from a smaller study which demonstrated significant improvements in all symptoms among veterans with Gulf War Illness after one month on the dietary intervention. The main objectives of this study are: 1) to confirm previous findings of treatment response to the diet in a larger and more diverse group; 2) to examine how changes in the nervous system may be the reason for improvement; and 3) to identify markers which change in the blood after one month on the diet. Participants will have baseline measures collected and then will be randomized into the intervention or wait-listed control group, which they will follow for one month before being reassessed.
Conditions Studied
Interventions
- BEHAVIORAL Dietary Intervention
Study Locations (3)
District of Columbia
- American University - Washington D.C.
Florida
- Nova Southeastern University - Fort Lauderdale
Massachusetts
- Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-12-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05675878
The ClinicalTrials.gov registry entry for NCT05675878 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 118-participant average among 14 other Gulf War Illness trials with a reported enrollment target (36% higher). The listed sponsor is American University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gulf War Illness appearing as the primary indexed condition, and to 1 intervention - of which Dietary Intervention is the first listed.
NCT05675878 reports 3 study locations spanning 3 distinct geographic areas - top geographies include District of Columbia, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05675878 about?
NCT05675878 is a clinical study titled "Confirmation of Diet as a Treatment for Gulf War Illness". This clinical trial aims to confirm previous findings from a smaller study which demonstrated significant improvements in all symptoms among veterans with Gulf War Illness after one month on the dietary intervention. The main objectives of this study are: 1) to confirm previous findings of treatment...
What is the current status of trial NCT05675878?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2023-03-01. Estimated completion is 2025-12-30.
What conditions does trial NCT05675878 study?
This clinical trial studies the following conditions: Gulf War Illness, Gulf War Syndrome.
What interventions are being tested in trial NCT05675878?
The interventions under investigation include: Dietary Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05675878?
This trial is sponsored by American University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675878 being conducted?
This trial has 3 study locations across District of Columbia, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Coenzyme Q10 Phase III Trial in Gulf War Illness
COMPLETED · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
-
Validating Gulf War Illness Blood Biomarkers
RECRUITING
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
-
Ca-Mg Butyrate in GWI
RECRUITING · Phase 2
-
Mechanisms of Gulf War Illness
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.